Carmen Guillén-Ponce

11PUBLICATIONS
56CO-AUTHORS
Predictive and prognostic markersMolecular targetsEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 30, 2026
Intravenous hyaluronidase-expressing oncolytic adenovirus with chemotherapy in metastatic pancreatic cancer: a randomized phase 2b trial.

|Sep 03, 2026
Prognostic modeling of overall survival in metastatic pancreatic cancer: an inflammation-based tool validated in PANTHEIA-SEOM cohort.

|Nov 14, 2024
A Phase III Randomized Trial of Integrated Genomics and Avatar Models for Personalized Treatment of Pancreatic Cancer: The AVATAR Trial.

Francesca Sarno, Jair Tenorio, Sofia Perea

|Sep 28, 2024
Constitutional Mutation of PIK3CA: A Variant of Cowden Syndrome?

Elena Vida-Navas, Verónica Barca-Tierno, Victoria López-Gómez

|Dec 23, 2022
Evolution of RAS Mutations in Cell-Free DNA of Patients with Tissue RAS Wild-Type Metastatic Colorectal Cancer Receiving First-Line Treatment: The PERSEIDA Study.

Manuel Valladares-Ayerbes, Pilar Garcia-Alfonso, Jorge Muñoz Luengo

|Mar 26, 2022
Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors.

Rocio Garcia-Carbonero, Miriam Bazan-Peregrino, Marta Gil-Martín

Pageof 2

Frequent Collaborators

2 joint publications

A Cervantes

2 joint publications

Bruno Bockorny

2 joint publications

Jaime Feliu

2 joint publications

Manuel Hidalgo